Tirzepatide dose tracker
Try the GLP-1 dose log with a fictional entry. No account needed. Reload to reset the demo.
Today
Tirzepatide
Ready to log
Today’s sample dose is ready to log.
Sample history
Previous sample dose
Logged
Keep your own dose history
Record doses on the schedule you already follow and review your history. Dosavy is a paid subscription, free in early access: every account is a founder account, with full access and no card.
Research example
Who took part in the SURMOUNT-1 tirzepatide trial?
The 72-week trial included 2,539 adults with obesity or with overweight and at least one weight-related health condition. The trial excluded people with diabetes.
Dosavy’s AI assistant draws on a curated library of published studies and prescribing information. Follow citations to check what a source actually studied.
Read the study abstract on PubMed